Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.586 USD | -3.92% | +1.36% | -94.71% |
24/05 | Allarity Therapeutics, Inc. Concludes Its Phase 2 Clinical Trial | CI |
06/05 | Allarity Therapeutics Says Stockholders' Equity 'Significantly' Exceeds Nasdaq's $2.5 Million Minimum Rule | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
188K | - | - | - | - | - | |
121B | ||||||
107B | ||||||
24.82B | - | |||||
22.48B | - | |||||
18.32B |